Webinars

The Hidden Complexity of Cancer Driver Mutations

Genetically engineered cell lines are fundamental tools for studying cancer biology, but maintaining stable edited clones can present unexpected challenges.

In this webinar, Dr. Ben Park will present findings from his recent PNAS publication investigating the long-term stability of cancer cells engineered with recurrent SF3B1 hotspot mutations.

The study reveals a surprising tendency for edited cells to revert toward the wild-type genotype over time and demonstrates how longitudinal monitoring of verified monoclonal populations provided new insight into the selective pressures acting on these mutations.

Dr. Park will discuss the experimental approach used to isolate, verify, and follow individual edited clones and the implications of these findings for disease modeling, genome editing, and cancer research.

You’ll Learn:

  • Why SF3B1 hotspot mutations can revert toward the wild-type genotype following genome editing in cancer cell lines.
  • How verified monoclonal colony tracking can improve confidence when establishing and monitoring edited cell lines.
  • Experimental approaches for isolating and following individual CRISPR-edited clones over extended culture periods.
  • What these findings reveal about the biology of SF3B1 mutations and the implications for future cancer models and functional studies.
Play Video Play Video

Presenters

Ben Ho Park, MD, PhD
Director, Vanderbilt-Ingram Cancer Center
Play Video Play Video